NCT07387601Recruiting
Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia
Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia: A Protocol for a Cluster- Randomized Controlled Trial Study
Source: ClinicalTrials.gov · Last updated 6 Jul 2026
Brief summary (registry, in English)
The study might come up with valuable findings to address poor treatment outcome, poor quality of life, disability score and depressive symptoms. The findings may also be decreased health professional workload. The findings would be supportive evidences for policy makers, program managers, to clinician as well as the patients themselves and for other researchers. The study may help to promote and maintain good treatment outcome for the patients in the study area as well as the country. The findings will also be used for teaching \& learning purposes in educational \& training programs.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 28 Jan 2026
- Start date
- 19 Feb 2026
- Primary completion date
- 12 Jul 2026
- Lead sponsor
- Bahirdar University
- Diseases
- Tuberculosis
- NCT number
- NCT07387601
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 19 Feb 2026 to the primary completion date, 12 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Tuberculosis patients with a known plan to be transferred out of the study sites
Other
- Seriously ill patients at the time of screening or enrollment
Who the study is looking for
- Adults with new drug-susceptible pulmonary TB who will be diagnosed in bacteriological diagnostic methods
- not participating in similar study,
- mentally capable to provide consent,
- physically capable of following the intervention.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jinka University Coordinator of this site? Confirm its status | Jinka | Ethiopia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.